Advanced breast cancer immunotherapy: Surface modification of NK cells for embedding antibody-drug conjugates

抗体-药物偶联物 医学 乳腺癌 免疫疗法 药品 抗体 结合 癌症免疫疗法 癌症研究 癌症 免疫学 药理学 单克隆抗体 内科学 数学 数学分析
作者
Su Yeon Lim,Seungmin Han,Yeo Hyung Kim,Hong Bin Kim,Yeongbeom Kim,Jeong‐Ann Park,Jina Yun,Seok‐Beom Yong,Young‐Wook Won,Kwang Suk Lim
出处
期刊:Biomedicine & Pharmacotherapy [Elsevier BV]
卷期号:189: 118245-118245 被引量:10
标识
DOI:10.1016/j.biopha.2025.118245
摘要

The combination of antibody-drug conjugates (ADCs) and immunotherapy has emerged as a promising strategy for cancer treatment. However, effective integration of chemotherapy and immunotherapy remains a challenge. Here, we introduce a universal surface-engineered NK (USE-NK) platform, which rapidly modifies immune cells into a targeted chemoimmunotherapy system by enabling the spontaneous incorporation of antibodies or ADCs. This platform utilizes a recombinant fusion protein (C3) derived from Protein G and a polymeric lipid-based conjugation strategy to stably attach therapeutic antibodies to NK cell surfaces without genetic modifications, preserving their native functionality. This approach enhances tumor targeting, minimizes off-target toxicity, and maintains NK cell cytotoxicity. Both in vitro and in vivo studies demonstrated that USE-NK conjugated with trastuzumab (TZ) or trastuzumab-emtansine (T-DM1) exhibited superior HER2-positive cancer cell recognition and cytotoxicity compared to NK cells treated with each agent separately. This enhancement was driven by the combined effects of 1) targeted delivery of potent chemotherapeutic agents with minimizing off-target toxicity, 2) enhanced mobilization of USE-NK toward tumor tissue, and 3) the cytotoxic activity of USE-NK against cancer cells. This rapid, non-invasive, and reversible engineering method provides a flexible approach to chemoimmunotherapy. Additionally, it extends beyond NK cells to other immune cell therapies, including CAR-T and CAR-NK cells. By leveraging the antibody-binding ability of C3, this platform enables multi-antigen targeting to address tumor heterogeneity. The scalability and adaptability of USE-NK position it as a promising candidate for personalized and off-the-shelf cancer immunotherapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
直率青筠发布了新的文献求助10
刚刚
阳光荠完成签到,获得积分20
2秒前
2秒前
英俊的铭的应助被锅锅采纳,获得10
3秒前
Orange的应助被哈哈哈哈st采纳,获得10
3秒前
3秒前
3秒前
wwwwzzzz发布了新的文献求助10
4秒前
彭于彦祖的应助被DD采纳,获得30
4秒前
4秒前
xixi发布了新的文献求助10
5秒前
可爱的函函的应助被直率青筠采纳,获得10
5秒前
5秒前
6秒前
6秒前
7秒前
7秒前
风汐5423发布了新的文献求助10
7秒前
7秒前
7秒前
7秒前
7秒前
Cheng发布了新的文献求助10
8秒前
8秒前
ldngis完成签到,获得积分10
8秒前
JUAN完成签到,获得积分10
8秒前
赘婿的应助被怪奇物语采纳,获得10
8秒前
小何的应助被ale采纳,获得10
8秒前
yu发布了新的文献求助30
9秒前
9秒前
阳光荠发布了新的文献求助10
9秒前
ZXDDDD发布了新的文献求助10
10秒前
Lunyx发布了新的文献求助30
10秒前
starry发布了新的文献求助10
11秒前
Lucas的应助被冰淇淋灭火器采纳,获得10
11秒前
吃饭饭发布了新的文献求助10
11秒前
Kare完成签到,获得积分10
12秒前
12秒前
1111发布了新的文献求助10
12秒前
酷酷的丝袜完成签到 ,获得积分20
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153492
求助须知:如何正确求助?哪些是违规求助? 9550166
关于积分的说明 21696892
捐赠科研通 7742051
什么是DOI,文献DOI怎么找? 3425502
关于科研通互助平台的介绍 2550620
邀请新用户注册赠送积分活动 2469156